Switch to:
More From Other Websites
AVEO Oncology Announces Completion of a CHMP Oral Explanation for Tivozanib as a Treatment of... May 19 2017
AVEO Announces Appointment of Matthew Dallas as Chief Financial Officer May 16 2017
AVEO Issues Statement Regarding the Passing of Lead Director Henri A. Termeer May 15 2017
AVEO Oncology Announces Receipt of USPTO Notice of Allowance Related to AV-353 May 08 2017
AVEO Pharmaceuticals (AVEO) Q1 Loss Narrower Than Expected May 05 2017
Today's Research Reports on Biotech Stocks to Watch: AVEO Pharmaceuticals and PharmAthene May 05 2017
AVEO reports 1Q loss May 04 2017
AVEO Reports First Quarter 2017 Financial Results and Provides Business Update May 04 2017
AVEO Pharmaceuticals (AVEO) Down 17.4% Since Earnings Report: Can It Rebound? Apr 24 2017
AVEO Announces Presentations at the 2017 ASCO Annual Meeting Apr 20 2017
AVEO Announces Submission of Response to Tivozanib Marketing Authorization Application Day 180 List... Apr 13 2017
AVEO Announces Milestone Payment from CANbridge for AV-203 Apr 03 2017
AVEO Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares Mar 31 2017
GGP, CenturyLink Drop into Tuesday’s 52-Week Low Club Mar 28 2017
AVEO Announces Pricing of $15.0 Million Public Offering of Common Stock Mar 28 2017
AVEO Announces Proposed Offering of Common Stock Mar 28 2017
AVEO (AVEO) Reports Narrower-than-Expected Loss in Q4 Mar 23 2017
AVEO Reports Full Year 2016 Financial Results and Provides Business Update Mar 22 2017
AVEO Announces First Patient Dosed in Phase 1/2 TiNivo Trial of Tivozanib and Opdivo® (nivolumab)... Mar 22 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK